CRP and cancer: We found that MMP-8 immunoexpression in cancer cells combined with a low plasma CRP level (<10 mg/L) is a strong predictor of a favourable outcome in PDAC, whereas no MMP-8 expression and an elevated CRP level (≥10 mg/L) predicts a poor prognosis.